Atlas Trials

A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Clinical trial NCT05641610 · RECRUITING

Trial details

NCT number
NCT05641610
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hemophilia B
Start date
2022-02-16
Primary completion
2025-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.